BioSpace News Archive

Pharmaceutical Research and Manufacturers of America President and CEO Stephen J. Ubl made the following statement after the U.S. Food and Drug Administration approved the first COVID-19 vaccine.

PharmaCyte Biotech, Inc. today announced the closing of its previously announced registered direct offering priced at-the-marked under Nasdaq rules, of 14,000,000 shares of the Company’s common stock

Cyclerion Therapeutics, Inc. today announced participation in the Annual Biomarkers for Alzheimer’s Disease Summit taking place virtually August 25-26, 2021.

Huntington Hospital has opened the Helen and Will Webster Heart & Vascular Center, the most comprehensive and innovative facility for cardiac care in the San Gabriel Valley.

Immunexpress today announced that the SeptiCyte® RAPID test will be evaluated in the diagnosis of paediatric sepsis in Queensland children.

Heat Biologics, Inc. announces the addition of Mark Pryor, former US Senator from the State of Arkansas, to the Company’s Biothreat Advisory Board.

Soligenix, Inc. announced today a publication describing the formulation of single-vial platform presentations of monovalent (single antigen), bivalent (two antigens) and trivalent (three antigens) combinations of filovirus vaccine candidates.

Bavarian Nordic A/S announced that the Company has entered a funding agreement with the Danish Ministry of Health to further advance the development of ABNCoV2, the Company’s COVID-19 vaccine candidate.

BriaCell Therapeutics Corp. announces it will be present at the H.C. Wainwright 23rd Annual Global Investment Conference

Todos Medical, Ltd. (OTCQB: TOMDF), a comprehensive medical diagnostics and related solutions company, today announced that its CLIA/CAP certified lab Provista Diagnostics has successfully completed the validation studies required to put the cPass Neutralizing Antibody Blood Test into production and expects to launch cPass in September 2021.